Patents by Inventor Audrey Hospital

Audrey Hospital has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 3,4,5-trisubstituted-1,2,4-triazoles and 3,4,5-trisubstituted-3-thio-1,2,4-triazoles and uses thereof
    Patent number: 11912687
    Abstract: The present disclosure describes novel compounds that are somatostatin receptor type 4 agonists.
    Type: Grant
    Filed: September 3, 2021
    Date of Patent: February 27, 2024
    Assignee: Board of Trustees of the Southern Illinois University
    Inventors: Kenneth A. Witt, Albert M. Crider, William Neumann, Audrey Hospital, Karin Sandoval, Maria Kontoyianni
  • KRAS modulators and uses thereof
    Patent number: 11912723
    Abstract: Provided herein are KRAS modulating compounds, such as compounds of Formula (I), (II), (II*), (III) or pharmaceutically acceptable salts, solvates, stereoisomers, atom labelled, or tautomers of any of the foregoing, useful for modulating KRAS GD12 and/or other G12 mutants.
    Type: Grant
    Filed: July 31, 2023
    Date of Patent: February 27, 2024
    Assignee: QUANTA THERAPEUTICS, INC.
    Inventors: Hong Lin, Juan Luengo, Neil Johnson, Audrey Hospital
  • KRAS MODULATORS AND USES THEREOF
    Publication number: 20230374042
    Abstract: Provided herein are KRAS modulating compounds, such as compounds of Formula (I), (II), (II*), (III) or pharmaceutically acceptable salts, solvates, stereoisomers, atom labelled, or tautomers of any of the foregoing, useful for modulating KRAS GD12 and/or other G12 mutants.
    Type: Application
    Filed: July 31, 2023
    Publication date: November 23, 2023
    Inventors: Hong LIN, Juan LUENGO, Neil JOHNSON, Audrey HOSPITAL
  • 3,4,5-Trisubstituted-1,2,4-Triazoles and 3,4,5-Trisubstituted-3-Thio-1,2,4-Triazoles and Uses Thereof
    Publication number: 20220002274
    Abstract: The present disclosure describes novel compounds that are somatostatin receptor type 4 agonists.
    Type: Application
    Filed: September 3, 2021
    Publication date: January 6, 2022
    Applicant: Board of Trustees of the Southern Illinois University
    Inventors: Kenneth A. Witt, Albert M. Crider, William Neumann, Audrey Hospital, Karin Sandoval, Maria Kontoyianni
  • 3,4,5-trisubstituted-1,2,4-triazoles and 3,4,5-trisubstituted-3-thio-1,2,4-triazoles and uses thereof
    Patent number: 11136312
    Abstract: The present disclosure describes novel compounds that are somatostatin receptor type 4 agonists.
    Type: Grant
    Filed: May 11, 2018
    Date of Patent: October 5, 2021
    Assignee: Board of Trustees of the Southern Illinois University
    Inventors: Kenneth A. Witt, Albert M. Crider, William Neumann, Audrey Hospital, Karin Sandoval, Maria Kontoyianni
  • 3,4,5-Trisubstituted-1,2,4-Triazoles and 3,4,5-Trisubstituted-3-Thio-1,2,4-Triazoles and Uses Thereof
    Publication number: 20200165230
    Abstract: The present disclosure describes novel compounds that are somatostatin receptor type 4 agonists.
    Type: Application
    Filed: May 11, 2018
    Publication date: May 28, 2020
    Inventors: Kenneth A. Witt, Albert M. Crider, William Neumann, Audrey Hospital, Karin Sandoval, Maria Kontoyianni